20 minute delayed
Join Market Matters and get full access to all our Opinion + Action
Undervalued
Morningstar Quantitative Rating as of 30 OCT 2026.
Quantitative Equity Rating Methodology – view here
Five-star price 3.23 Fair value 3.67 One-star price 4.17
Morningstar Quantitative Rating as of 30 OCT 2026.
Morningstar Quantitative Rating as of 30 OCT 2026. The slider runs from the five-star price (3.23) to the one-star price (4.17).
| Ratios |
|---|
| Currency (Price/reporting): AUD/AUD |
| Exchange Rate: 1.0000 |
| Price - closing or last bid | 3.17 |
| Price - 12 month high | 3.37 |
| Price - 12 month low | 1.79 |
| Pricing date | 29 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 0.92 |
| Market capitalization | 1,218.18 |
| 12 Month High price date | 3 SEP 2026 |
| 12 Month Low price date | 25 MAR 2026 |
| Volume - avg. trading volume for the last 3 months | 1.13 |
| Price - 1 Day % Change | 1.60% |
| Price - 13 week price percent change | 8.93% |
| Price - 26 week price percent change | 30.45% |
| Price - 5 Day % Change | 5.32% |
| Price - 52 week price percent change | 48.13% |
| Price - YTD price percent change | 34.89% |
| Price % Change Month To Date | -0.63% |
| EPS excluding extraordinary items - most recent fiscal year | -0.432 |
| EPS excluding extraordinary items - trailing 12 month | -0.409 |
| EPS Normalized - most recent fiscal year | -0.116 |
| Revenue/share - most recent fiscal year | 8.991 |
| Revenue/share - trailing 12 month | 8.726 |
| Book value per share - most recent fiscal year | 5.510 |
| Book value per share - most recent half-year | 4.725 |
| Book value (tangible) per share - most recent fiscal year | 2.437 |
| Book value (tangible) per share - most recent half-year | 2.518 |
| Cash per share - most recent fiscal year | 1.239 |
| Cash per share - most recent half-year | 0.932 |
| Cash Flow per share - most recent fiscal year | 0.425 |
| Cash Flow per share - trailing 12 month | 0.710 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.000 |
| EBITD per share - trailing 12 month | 0.417 |
| EPS Basic excluding extraordinary items - most recent fiscal year | -0.432 |
| EPS Basic excluding extraordinary items - trailing 12 month | -0.410 |
| EPS including extraordinary items - most recent fiscal year | -0.432 |
| EPS including extraordinary items - trailing 12 month | -0.410 |
| Free Cash Flow per share - trailing 12 month | 0.282 |
| P/E excluding extraordinary items, most recent fiscal year | — |
| P/E Normalized, most recent fiscal year | 813.24 |
| Price to sales - most recent fiscal year | 0.36 |
| Price to Tangible Book - most fiscal year | 1.69 |
| Price to Free Cash Flow per Share - most recent fiscal year | 11.24 |
| Price to Cash Flow per share - trailing 12 month | 4.47 |
| Price to Book - most recent fiscal year | 0.67 |
| P/E excluding extraordinary items high, trailing 12 months | — |
| P/E excluding extraordinary items low, trailing 12 months | — |
| Net Debt, LFI | 1,227.07 |
| Net Debt, LFY | 824.20 |
| Dividend Yield - 5 Year Average | — |
| Dividend Yield - indicated annual dividend divided by closing price | — |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 0.00% |
| Free Cash Flow - most recent fiscal year | -75.60 |
| LT debt/equity - most recent fiscal year | 48.98% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 61.55% |
| LT debt/equity - most recent half-year | 63.48% |
| Total debt/total equity - most recent half-year | 76.86% |
| Free Cash Flow - trailing 12 month | 108.20 |
| Payout ratio - trailing 12 month | — |
| Revenue - most recent fiscal year | 3,443.38 |
| Revenue - trailing 12 month | 3,346.82 |
| EBITD - most recent fiscal year | 141.62 |
| EBITD - trailing 12 month | 160.11 |
| Earnings before taxes - most recent fiscal year | -175.30 |
| Earnings before taxes - trailing 12 month | -158.77 |
| Net Income available to common - most recent fiscal year | -165.32 |
| Net Income available to common - trailing 12 months | -156.87 |
| Earnings before taxes Normalized - most recent fiscal year | -99.55 |
| Net Income Available to Common, Normalized - most recent fiscal year | -22.87 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 0.00 |
| Net Profit Margin % - 1st historical fiscal year | -4.80% |
| Net Profit Margin % - trailing 12 month | -4.69% |
| Operating margin - 1st historical fiscal year | -2.27% |
| Operating margin - trailing 12 month | -1.61% |
| Pretax margin - trailing 12 month | -4.74% |
| Pretax margin - 1st historical fiscal year | -5.09% |
| Operating Margin - 5 year average | 3.10% |
| Pretax Margin - 5 year average | 0.88% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 0.41% |
| Free Operating Cash Flow/Revenue, TTM | 3.23% |
| Net Profit Margin - 5 year average | 0.62% |
| Return on average assets - most recent fiscal year | -3.47% |
| Return on average assets - trailing 12 month | -3.21% |
| Return on average equity - most recent fiscal year | -7.77% |
| Return on average equity - trailing 12 month | -7.86% |
| Return on average assets - 5 year average | 0.46% |
| Return on average equity - 5 year average | 1.09% |
| Net Income/employee - most recent fiscal year | — |
| Revenue/employee - most recent fiscal year | — |
| Revenue growth rate, 5 year | — |
| EPS growth rate, 5 year | — |
| Growth rate% - dividend, 3 year | — |
| Revenue/share (5 yr growth) | — |
| Growth rate% - Revenue, 3 year | -3.00% |
| Growth rate% - EPS, 3 year | — |
| Book value per share growth rate, 5 year | 3.05% |
| Capital Spending growth rate, 5 year | — |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | — |
Financial forecast (AUD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | |||||
| Estimate breakdown | ||||||||
Financials (AUD, millions)
| Period end: | SEP 21 | SEP 22 | SEP 23 | SEP 24 | SEP 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Announcements
| DATE | TIME | HEADING | PAGES |
| Price sensitive |
NUF +3.37%: Held their FY24 AGM and provided a decent trading update, mostly reiterating what was set out in the November 2024 full-year result. Things are looking better, margins are improving as the cost of inputs remains the same, an indicator they are cleaning things up on the operational side.
NUF -9.8%: This was not an FY24 result from the agricultural chemical business, just an old-fashioned surprise downgrade that led to the stock's hammering on Thursday; perhaps boss Greg Hunt hoped it would go unnoticed amongst the plethora of earnings news.
NUF -7.07%: The volatility continued today for Ag related stocks with Nufarm materially missing expectations at their 1H24 results, while their FY24 earnings guidance was also weak. The stock was hit hard early , down 13.5% at its worst testing its 12-month low in the process, before recouping half of the losses. Once the conference call started though, things improved amid some confidence that this may be the low point emerged.
Nufarm (NUF) is a global pesticide business with a strong local presence, they have endured issues through periods of sustained drought but theoretically will outperform in high yield crop years i.e. similar to IPL it comes with weather risks. The company reports today hence volatility is likely to be elevated as it has been for both IPL and ELD after their respective earnings. The stock closed yesterday within a few cents of its average for the last 3 ½ years hence we see reason to 2nd guess what comes next until we see some meaningful direction from the company.
Global pesticide company NUF has endured a fortnight to forget as its shares have tumbled 26% following the news that major shareholder Sumitomo had sold their 1.9% stake in the business at an average price of $5.38, well below the average level of recent weeks but already 7% above yesterdays close. The previously largest shareholder crystallised a painful loss after buying into NUF post the GFC at $14...
Agricultural chemical business NUF was whacked -8.6% yesterday to head the losers board for the main index, weakness followed the release of its half-year results. Another classic case of an ok result not being good enough in today’s fickle and nervous market i.e. EBITDA came in up 41% a $330mn, smack in the middle of the company’s $320mn-$340mn guidance. With food prices set to remain elevated over the coming years, we like NUF into pullbacks
NUF +20.22%: a strong day from the crop protection and seed technology business on the back of a bumper 1st quarter. Quarterly revenue has jumped 36% vs the first quarter last year with good weather driving demand across both segments. Costs pressures are coming through though with higher raw materials and logistics costs softening...
Yesterday saw NUF’s stock plunge 8.57% making it the worst performer in the ASX200, the Agribusiness released its annual results and while it may have grown revenue it suffered because of rising freight and storage costs. Most importantly it cautioned investors that the rising costs of materials and supply chain issues would damage margins however they do have the ability to hike prices to maintain profitability.
Manufacturer of seed and crop protection products NUF has struggled for the last 4-years and buying current weakness makes me think of “catching the falling knife”, historically an excellent way to lose money. The company lost ~$80m in FY20 and while it’s tipped to return to profitability in FY21 to the tune of $61m, the markets clearly not a believer and ”fighting the tape” can be dangerous, especially with stocks in pronounced downtrends.
MM remains neutral NUF
MM has no interest in NUF
MM remains neutral NUF
MM is neutral towards NUF
MM is neutral NUF
MM likes NUF around $6
MM is neutral NUF, but clearly some good momentum in the business
MM believes NUF will be interesting around $4
MM is neutral NUF
Nufarm Limited is a global crop-protection company that develops, manufactures, and sells a range of crop-protection products, including herbicides, insecticides, and fungicides. Nufarm sells its products in most of the world's major agricultural regions and operates primarily in the off-patent segment of the crop-protection market. Nufarm operates along two business lines: crop protection and seed technologies.
Forgot password? Request a One Time Password or reset your password
One Time Password
Check your email for an email from [email protected]
Subject: Your OTP for Account Access
This email will have a code you can use as your One Time Password for instant access
A link to create a new password will be sent to the email address you have registered to your account.
Hi, this is only available to members. Join today and access the latest views on the latest developments from a professional money manager.
Our Smart Phone App will give you access to much of our content and notifications. Download for free today.
Hi, this is only available to members. Join today and access the latest views on the latest developments from a professional money manager.
JOIN NOW
Something went wrong. Please try again in a moment.
